Debt-to-equity of Indaptus Therapeutics, Inc. from 30 Sep 2022 to 31 Dec 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Indaptus Therapeutics, Inc. quarterly Debt-to-equity in % history and change rate from 30 Sep 2022 to 31 Dec 2024.
  • Indaptus Therapeutics, Inc. Debt-to-equity for the quarter ending 31 Dec 2024 was 36%, a 155% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Indaptus Therapeutics, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q4 2024 36% +22% +155% 31 Dec 2024
Q3 2024 26% +13% +103% 30 Sep 2024
Q2 2024 21% +9% +81% 30 Jun 2024
Q1 2024 16% +5% +43% 31 Mar 2024
Q4 2023 14% +2% +19% 31 Dec 2023
Q3 2023 13% +1% +7.5% 30 Sep 2023
Q2 2023 11% 30 Jun 2023
Q1 2023 11% 31 Mar 2023
Q4 2022 12% 31 Dec 2022
Q3 2022 12% 30 Sep 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.